Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03244917 · ClinicalTrials.gov registry record · NA
Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias
A NA study, sponsored by Hebrew SeniorLife.
- Completed
- Registry status
- NA
- Development phase
- 430
- Enrollment target
NCT03244917 is a NA study that has completed, run by Hebrew SeniorLife. The registered enrollment target is 430 participants.
The verdict
NCT03244917, a NA study, has completed, sponsored by Hebrew SeniorLife.
- COMPLETED
- Registry status
- NA
- Development phase
- 430 participants
- Enrollment target
Study Summary
This is a 52-month study (8 months preparation; 36 months to conduct the trial; 8 months data analyses and manuscript preparation) of a cluster randomized controlled trial (RCT) of an intervention to improve infection management for suspected UTIs and LRIs among residents with advanced dementia (N=480; N=240/arm) living in NHs (N=24; N=12/arm). The NH is the unit of randomization as the intervention must be delivered at the facility level to avoid contamination and because this is how it would be employed in the real-world. Analyses will be at the patient level.
Interventions
- BEHAVIORAL TRAIN-AD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2017-10-15 |
| Est. Completion | 2020-03-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03244917
The ClinicalTrials.gov registry entry for NCT03244917 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 430 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hebrew SeniorLife, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TRAIN-AD is the first listed.
NCT03244917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03244917 about?
NCT03244917 is a clinical study titled "Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias". This is a 52-month study (8 months preparation; 36 months to conduct the trial; 8 months data analyses and manuscript preparation) of a cluster randomized controlled trial (RCT) of an intervention to improve infection management for suspected UTIs and LRIs among residents with advanced dementia (N=4...
What is the current status of trial NCT03244917?
This trial is currently completed. It is a NA study. The enrollment target is 430 participants. The study started on 2017-10-15. Estimated completion is 2020-03-10.
What interventions are being tested in trial NCT03244917?
The interventions under investigation include: TRAIN-AD (BEHAVIORAL).
Who is sponsoring clinical trial NCT03244917?
This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.